J. Koh

A Warhead Substitution Study on the Coronavirus Main Protease Inhibitor Nirmatrelvir

Boping Liu, Xiaoying Koh, J. Joy, 2022, ACS medicinal chemistry letters.

Phenotype-driven precision oncology as a guide for clinical decisions one patient at a time

Denis Bertrand, Giridharan Periyasamy, Alexander Lezhava, 2017, Nature Communications.

A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC)

F. Chong, N. Iyer, S. Rikka, 2021, EBioMedicine.

Phenotype-driven precision oncology as a guide for clinical decisions one patient at a time

F. Chong, R. Dasgupta, I. Tan, 2017, Nature Communications.